Real-World Outcomes and Prognostic Factors of Polymyxin B Hemoperfusion in Severe Sepsis and Septic Shock: A Seven-Year Single-Center Cohort Study from Taiwan

<b>Background</b>: Severe sepsis and septic shock remain major contributors to ICU mortality. Polymyxin B hemoperfusion (PMX-HP) has been widely adopted as adjunctive therapy in Asian ICUs for endotoxemia, but its real-world effectiveness and prognostic factors remain uncertain, especially in high G...

Descrición completa

Detalles Bibliográficos

Principais autores:	Wei-Hung Chang, Ting-Yu Hu, Li-Kuo Kuo
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2025-08-01
Series:	Life
Assuntos:	polymyxin B hemoperfusion severe sepsis septic shock intensive care unit endotoxemia APACHE II score
Acceso en liña:	https://www.mdpi.com/2075-1729/15/8/1317
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!